Immunohistochemical expression of OCT4 in primary central nervous system germ cell tumours
- PMID: 17997317
- DOI: 10.1016/j.jocn.2006.08.013
Immunohistochemical expression of OCT4 in primary central nervous system germ cell tumours
Abstract
OCT4 is a POU-domain transcription factor that is expressed in embryonic stem cells and germ cells. OCT4 has been detected in specific types of testicular germ cell tumour (GCT), including seminoma and embryonal carcinoma. The aim of this study was to evaluate the role of OCT4 expression in the diagnosis of primary central nervous system (CNS) pure and mixed GCT. Seventeen formalin-fixed, paraffin-embedded tissues of primary CNS GCT were immunohistochemically studied. The 12 pure GCT samples comprised germinoma (5), yolk sac tumour (3), mature teratoma (2), and immature teratoma (2). The five cases of mixed GCT contained various components as follows: yolk sac tumour (4), embryonal carcinoma (3), mature teratoma (1), germinoma (2), polyembryoma (1) and immature teratoma (1). Diffuse and strong nuclear staining indicating OCT4 expression was detected in all cases of pure germinoma (5), and in all cases of mixed GCT containing embryonal carcinoma (3) and/or germinoma (2). There was no corresponding staining in pure GCT of yolk sac tumour, mature teratoma, or immature teratoma except in a primitive neuroectodermal component, or in mixed GCT containing components of yolk sac tumour, mature teratoma or immature teratoma. In conclusion, we found that OCT4 immunostaining is a useful diagnostic tool to assist in the identification of primary CNS embryonal carcinoma and germinoma. In CNS mixed GCT, OCT4 expression can be detected provided that the components include embryonal carcinoma and/or germinoma.
Similar articles
-
Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.Mod Pathol. 2005 Feb;18 Suppl 2:S61-79. doi: 10.1038/modpathol.3800310. Mod Pathol. 2005. PMID: 15761467 Review.
-
Morphologic, immunohistochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma.Hum Pathol. 2010 May;41(5):716-23. doi: 10.1016/j.humpath.2009.10.016. Epub 2010 Jan 21. Hum Pathol. 2010. PMID: 20096442
-
[Expression and diagnostic significance of OCT4, CD117 and CD30 in germ cell tumors].Zhonghua Bing Li Xue Za Zhi. 2005 Nov;34(11):711-5. Zhonghua Bing Li Xue Za Zhi. 2005. PMID: 16536313 Chinese.
-
POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors.Cancer Res. 2003 May 1;63(9):2244-50. Cancer Res. 2003. PMID: 12727846
-
OCT4: biological functions and clinical applications as a marker of germ cell neoplasia.J Pathol. 2007 Jan;211(1):1-9. doi: 10.1002/path.2105. J Pathol. 2007. PMID: 17117392 Review.
Cited by
-
HESRG: a novel biomarker for intracranial germinoma and embryonal carcinoma.J Neurooncol. 2012 Jan;106(2):251-9. doi: 10.1007/s11060-011-0673-7. Epub 2011 Aug 23. J Neurooncol. 2012. PMID: 21861197
-
Expression of Stemness Markers in the Cervical Smear of Patients with Cervical Insufficiency.Cells. 2023 Apr 18;12(8):1183. doi: 10.3390/cells12081183. Cells. 2023. PMID: 37190092 Free PMC article.
-
CRX is a diagnostic marker of retinal and pineal lineage tumors.PLoS One. 2009 Nov 20;4(11):e7932. doi: 10.1371/journal.pone.0007932. PLoS One. 2009. PMID: 19936203 Free PMC article.
-
OCT3/4 is a potential immunohistochemical biomarker for diagnosis and prognosis of primary intracranial germ cell tumors: a systematic review and meta-analysis.Front Neurosci. 2023 Jul 5;17:1169179. doi: 10.3389/fnins.2023.1169179. eCollection 2023. Front Neurosci. 2023. PMID: 37476834 Free PMC article. Review.
-
Pineal germ cell tumors: Two cases with review of histopathologies and biomarkers.J Clin Neurosci. 2017 Apr;38:23-31. doi: 10.1016/j.jocn.2016.12.024. Epub 2017 Feb 8. J Clin Neurosci. 2017. PMID: 28189312 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources